Drug intelligence / Profile preview

cannabidiol + hemp oil

Development stage
Unknown
Lead developer
C³ Cannabinoid Compound
Modality
Small Molecules
Administration
Oral, Sublingual, Topical, Inhalation
01

Overview

**Cannabidiol + hemp oil** is a combination containing **cannabidiol (CBD)**, a non-psychoactive phytocannabinoid found primarily in hemp, and **hemp oil**, typically referring to oil extracted from the seeds of the hemp plant, *Cannabis sativa*. This combination is commonly marketed and used as a dietary supplement. Cannabidiol interacts with multiple physiological targets in the endocannabinoid system, including cannabinoid receptors CB1 and CB2. It acts primarily as a negative allosteric modulator at the CB1 receptor, with additional effects on serotonin and other neural pathways. Hemp oil predominantly contains fatty acids, vitamins, and antioxidants, and may contain varying small amounts of cannabinoids depending on the manufacturing process. The combination is promoted for wellness purposes, such as relief from pain, anxiety, inflammation, and other indications, but only prescription cannabidiol (as Epidiolex) is FDA-approved for specific seizure disorders.

02

Targets

CNR1 (Cannabinoid receptor 1)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))

Beyond the preview

Go deeper on cannabidiol + hemp oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cannabidiol + hemp oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call